Disruption of IKAROS activity in primitive CML-CP cells can mimic myeloid disease progression (CML-AP), revealing that loss of IKAROS is a frequent step and potential predictor of BCR-ABL1-positive CML-AP/BC [162]. The gene discussed is IKZF1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.